Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema

Docetaxel (DTX) is an effective commercial anticancer agent for chemotherapy in non–small cell lung cancer (NSCLC), breast cancer, gastric cancer, and prostate cancer, but its adverse effects including edema, neurotoxicity, and hair loss limit its application. To improve the chemotherapeutic efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Hyun-Kyung, Kim, Kyoung Mee, Jeong, Seong-Yun, Choi, Eun Kyung, Jung, Joohee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739130/
https://www.ncbi.nlm.nih.gov/pubmed/27151585
http://dx.doi.org/10.1177/1534735416645184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739130/
https://www.ncbi.nlm.nih.gov/pubmed/27151585
http://dx.doi.org/10.1177/1534735416645184

Ejemplares similares